Home Cart Sign in  
Chemical Structure| 176957-55-4 Chemical Structure| 176957-55-4

Structure of CCT007093
CAS No.: 176957-55-4

Chemical Structure| 176957-55-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

CCT007093 is an effective PPM1D inhibitor with IC50 of 8.4 μM, that selectively reduces viability of human tumour cell lines.

Synonyms: CCT007093

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of CCT007093

CAS No. :176957-55-4
Formula : C15H12OS2
M.W : 272.39
SMILES Code : O=C1/C(CC/C1=C\C2=CC=CS2)=C/C3=CC=CS3
Synonyms :
CCT007093
MDL No. :MFCD00121546
InChI Key :KPFZCKDPBMGECB-WGDLNXRISA-N
Pubchem ID :2314623

Safety of CCT007093

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HEK293T cells 25 μM 1 h Co-immunoprecipitation confirmed direct interaction between YY1 and Wip1, suggesting CCT007093 may enhance YY1 phosphorylation by inhibiting Wip1. Front Immunol. 2025 May 9;16:1548814
Jurkat T cells 25 μM 16 h RNA sequencing analysis revealed that p65 NF-κB and YY1 are the primary targets of CCT007093-mediated Wip1 inhibition, leading to downregulation of PD-1 and FcγRIIB. Front Immunol. 2025 May 9;16:1548814
BJAB B cells 2 or 5 μM 24 h To evaluate the effect of CCT007093 on the transcriptional activities of PD-1 and FcγRIIB gene promoters, results showed that the shortest promoters (-936 bp of PD-1 gene and -600 bp of FcγRIIB gene) remained sensitive to CCT007093 inhibition. Front Immunol. 2025 May 9;16:1548814
MDA-MB-468 5 μM 72 h To evaluate the effect of CCT007093 alone and in combination with paclitaxel on cell growth. Results showed that CCT007093 alone had minimal effect on MDA-MB-468 cell growth (<15% inhibition), but in combination with paclitaxel, the inhibition rate reached 55%. Breast Cancer Res. 2010;12(3):R41
MDA-MB-231 5 μM 72 h To evaluate the effect of CCT007093 alone and in combination with paclitaxel on cell growth. Results showed that CCT007093 alone had minimal effect on MDA-MB-231 cell growth (<15% inhibition), but in combination with paclitaxel, the inhibition rate reached 47%. Breast Cancer Res. 2010;12(3):R41
MCF-7 5 μM 72 h To evaluate the effect of CCT007093 alone and in combination with paclitaxel on cell growth. Results showed that CCT007093 alone inhibited MCF-7 cell growth by 38%, and in combination with paclitaxel, the inhibition rate reached 79%. Breast Cancer Res. 2010;12(3):R41
D556 cells 0.05–5 μM 6 days Inhibits growth of WIP1 high-expressing medulloblastoma cells Neuro Oncol. 2012 Apr;14(4):440-58

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Optic nerve injury model Intraperitoneal injection 3.2 mg/kg Twice a day, used together with resveratrol Activating mTORC1 could reverse the function of SIRT1 in regulating the process of microglial activation mediated RGCs loss. J Inflamm Res. 2021 Dec 14;14:6857-6869
C57BL/6J mice Chronic hepatitis B virus (HBV) infection model Not specified 3.5 mg/kg/day Once daily for 14 days To evaluate CCT007093's effect on alleviating immune exhaustion in chronic HBV-infected mice, results showed significant reduction in serum HBsAg levels, decreased PD-1 and FcγRIIB expression in lymphocytes, and enhanced antiviral responses of intrahepatic lymphocytes. Front Immunol. 2025 May 9;16:1548814

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.67mL

0.73mL

0.37mL

18.36mL

3.67mL

1.84mL

36.71mL

7.34mL

3.67mL

References

 

Historical Records

Categories